1.上海中医药大学 中医学院,上海 201203
2.上海中医药大学 附属曙光医院, 国家中医药管理局中药制剂三级实验室,肝病研究所,肝肾疾病病证教育部重点实验室,上海 201203
3.上海市浦东新区北蔡社区卫生服务中心,上海 201204
林圣,在读硕士,从事中医药防治慢性肝病研究,E-mail:kklilili93@163.com
徐莹,博士,副教授,从事中医药防治慢性肝病研究,E-mail:xuying_doctor@shutcm.edu.cn
收稿:2025-12-25,
修回:2026-03-04,
录用:2026-03-25,
网络首发:2026-04-27,
移动端阅览
林圣, 付国胜, 张瑛, 等. UHPLC-Q-Orbitrap HRMS鉴定茵陈五苓散的化学成分与小鼠灌胃后的吸收成分[J/OL]. 中国实验方剂学杂志, 2026,1-8.
LIN Sheng, FU Guosheng, ZHANG Ying, et al. Identification of Chemical Components of Yinchen Wulingsan and Their Absorption Profiles Following Oral Administration in Mice by UHPLC-Q-Orbitrap HRMS[J/OL]. Chinese Journal of Experimental Traditional Medical Formulae, 2026, 1-8.
林圣, 付国胜, 张瑛, 等. UHPLC-Q-Orbitrap HRMS鉴定茵陈五苓散的化学成分与小鼠灌胃后的吸收成分[J/OL]. 中国实验方剂学杂志, 2026,1-8. DOI: 10.13422/j.cnki.syfjx.20260362.
LIN Sheng, FU Guosheng, ZHANG Ying, et al. Identification of Chemical Components of Yinchen Wulingsan and Their Absorption Profiles Following Oral Administration in Mice by UHPLC-Q-Orbitrap HRMS[J/OL]. Chinese Journal of Experimental Traditional Medical Formulae, 2026, 1-8. DOI: 10.13422/j.cnki.syfjx.20260362.
目的
2
采用超高效液相色谱-四极杆-静电场轨道阱高分辨质谱法(UHPLC-Q-Orbitrap HRMS)快速鉴定茵陈五苓散的化学成分及小鼠血清和组织中的吸收成分。
方法
2
取健康雄性C57/BL6J小鼠(
n
=12),空白组(
n
=3)灌胃纯化水,给药组(
n
=9)按10.28 g·kg
-1
灌胃茵陈五苓散提取液,分别在给药后0.5、1.5、3 h各处理3只,收集血清和肺、心、脾、肝、肾、回肠组织样本。质谱采集数据后,综合离子峰相对保留时间、精确相对分子量等信息,Xcalibur 4.2软件拟合组成元素。通过对照品、文献及数据库提供的二级质谱裂解碎片信息比对,实现对茵陈五苓散化学成分及入血、各组织原型移行成分的鉴定。
结果
2
从茵陈五苓散中共鉴定出208种化学成分,包括萜类107种、黄酮类41种、有机酸类23种、其他类11种、甾体类10种、香豆素10种、生物碱类及蒽醌类各3种。小鼠灌胃茵陈五苓散后,分别在血清0.5、1.5、3 h,肺,心,肝,脾,肾及回肠中鉴定出48、43、40、56、32、45、56、50、59种原型成分。其中泽泻醇A、茵陈蒿酸A、泽泻醇J-23-乙酸酯、4-酮基-白术内酯Ⅲ、13
β
,17
β
-环氧泽泻醇B、红花黄色素A、猪苓酮A、猪苓酮B等20个成分在血清和各组织中均有暴露,可能为潜在药效物质基础。
结论
2
该研究可明确茵陈五苓散物质基础以萜类、黄酮类及有机酸类成分为主,为后续药效物质在血清及组织中的药代动力学研究提供参考。
Objective
2
To rapidly identify the chemical constituents of Yinchen Wulingsan and its absorbed components in the serum and tissues of mice by ultra-high performance liquid chromatography-quadrupole-orbitrap high resolution mass spectrometry(UHPLC-Q-Orbitrap HRMS).
Methods
2
Healthy male C57/BL6J mice(
n
=12) were divided into the blank group(
n
=3) and treatment group(
n
=9). The blank group received purified water via intragastric administration, while the treatment group was given Yinchen Wulingsan extract at a dose of 10.28 g·kg
-1
via intragastric administration. At 0.5, 1.5, 3 h post-administration, 3 mice from the treatment group were processed at each time point. Serum and tissue samples from the lung, heart, spleen, liver, kidney, and ileum were collected. Following MS data acquisition, the relative retention time of ion peaks and accurate relative molecular mass were integrated, and elemental compositions were fitted using Xcalibur 4.2 software. The chemical constituents of Yinchen Wulingsan, as well as the prototype compounds absorbed into the blood and distributed in various tissues, were identified by comparing secondary MS fragmentation information with reference substances, literature, and database entries.
Results
2
A total of 208 chemical constituents were identified from Yinchen Wulingsan, including 107 terpenoids, 41 flavonoids, 23 organic acids, 11 compounds of other categories, 10 steroids, 10 coumarins, and 3 compounds each of alkaloids and anthraquinones. At 0.5, 1.5, 3 h after intragastric administration of Yinchen Wulingsan to mice, 48, 43, 40 prototype components were detected in the serum, respectively. Additionally, 56, 32, 45, 56, 50, 59 prototype components were identified in the lung, heart, liver, spleen, kidney, and ileum, respectively. Among these, twenty components such as alisol A, capillartemisin A and alisol J-23-acetate were detected in both the serum and all examined tissues, suggesting they may serve as the potential active constituents.
Conclusion
2
This study identifies terpenoids, flavonoids, and organic acids as the main constituents of Yinchen Wulingsan, providing a reference for subsequent pharmacokinetic studies of these bioactive components in serum and tissues.
范永升 , 姜德友 . 金匮要略·全国中医药行业高等教育“十四五”规划教材 [M]. 北京 : 中国中医药出版社 , 2021 : 182 .
FAN Y S , JIANG D Y . Synopsis of the Golden Chamber:The "14 th Five-Year Plan" Textbook for Higher Education in the National Traditional Chinese Medicine Industry [M]. Beijing : China Press Tradit Chin Med , 2021 : 182 .
朱丹 , 孙婷婷 , 陈兰羽 . 《金匮要略》诸方治疗非酒精性脂肪性肝病进展 [J]. 长春中医药大学学报 , 2016 , 32 ( 2 ): 423 - 425,429 .
ZHU D , SUN T T , CHEN L Y . Progress on formulas in Jingui Yaolue for treating non-alcoholic fatty liver disease [J]. J Changchun Univ Chin Med , 2016 , 32 ( 2 ), 423 - 425,429 .
朱小区 . 黄疸“于寒湿中求之”之我见 [J]. 浙江中医杂志 , 2018 , 53 ( 11 ): 851 .
ZHU X Q . My perspective on "seeking treatment from cold-dampness" for jaundice [J]. Zhejiang J Tradit Chin Med , 2018 , 53 ( 11 ): 851 .
YOU L P , WANG K X , LIN J C , et al . Yin-chen Wu-ling powder alleviate cholestatic liver disease:Network pharmacological analysis and experimental validation [J]. Gene , 2023 , 851 : 146973 .
ULICNÁ O , GREKSÁK M , VANCOVÁ O , et al . Hepatoprotective effect of rooibos tea ( Aspalathus linearis ) on CCl 4 -induced liver damage in rats [J]. Physiol Res , 2003 , 52 ( 4 ): 461 - 466 .
LU C , LI Y , HU S , et al . Scoparone prevents IL-1 β -induced inflammatory response in human osteoarthritis chondrocytes through the PI3K/Akt/NF- κ B pathway [J]. Biomed Pharmacother , 2018 , 109 ( 106 ): 1169 - 1174 .
YAHAGI T , YAKURA N , MATSUZAKI K , et al . Inhibitory effect of chemical constituents from Artemisia scoparia Waldst. et Kit.on triglyceride accumulation in 3T3-L1 cells and nitric oxide production in RAW 264.7 cells [J]. J Nat Med , 2014 , 68 ( 2 ): 414 - 420 .
郑丁 . 加味茵陈五苓散治疗非酒精性脂肪性肝炎(湿热蕴结证)的临床观察及机制研究 [D]. 武汉 : 湖北中医药大学 , 2021 .
ZHENG D . A clinical observation and mechanism study of modified Yinchen Wulingsan in treating non-alcoholic steatohepatitis (dampness-heat accumulation syndrome) [D]. Wuhan : Hubei University Chinese Mendicine , 2021 .
李思韵 , 蔡宏桂 , 张珏 , 等 . 茵陈五苓散加减治疗2型糖尿病临床研究 [J]. 新中医 , 2024 , 56 ( 11 ): 7 - 11 .
LI S Y , CAI H G , ZHANG J , et al . Modified Yinchen Wulingsan in treating type 2 diabetes mellitus:A clinical study [J]. New Chin Med , 2024 , 56 ( 11 ): 7 - 11 .
陈凌利 , 韦雯璐 , 李建明 , 等 . 茵陈蒿黄酮的提取、化学组成及生物活性研究进展 [J]. 江西农业大学学报 , 2024 , 46 ( 2 ): 263 - 277 .
CHEN L L , WEI W L , LI J M , et al . Research progress on extraction,chemical composition,and biological activities of flavonoids from Artemisia capillaris [J]. Acta Agric Univ Jiangxiensis , 2024 , 46 ( 2 ): 263 - 277 .
肖先 , 荆云 , 李春燕 , 等 . 泽泻主要化学成分及药理作用研究进展 [J]. 新乡医学院学报 , 2024 , 41 ( 4 ): 378 - 382 .
XIAO X , JING Y , LI C Y , et al . Research progress on main chemical constituents and pharmacological effects of Alismatis Rhizoma [J]. J Xinxiang Med Univ , 2024 , 41 ( 4 ): 378 - 382 .
王永丽 , 黄广建 , 刘从进 , 等 . UHPLC-Q-Exactive Orbitrap HRMS分析黄连解毒汤的化学成分及大鼠组织分布 [J]. 中草药 , 2022 , 53 ( 22 ): 6985 - 7000 .
WNG Y L , HUANG G J , LIU C J , et al . Analysis of chemical constituents in Huanglian Jiedu decoction and their tissue distribution in rats by UHPLC-Q-Exactive orbitrap HRMS [J]. Chin Tradit Herb Drugs , 2022 , 53 ( 22 ): 6985 - 7000 .
闫雅婕 , 王亚亚 , 梁轩 , 等 . 茵陈化学成分、药理作用及在肝胆疾病中的临床应用研究进展 [J]. 中华中医药学刊 , 2024 , 42 ( 11 ): 237 - 248 .
YAN Y J , WANG Y Y , LIANG X , et al . Research progress on chemical constituents,pharmacological effects,and clinical application in hepatobiliary diseases of Artemisia capillaris [J]. Chin Arch Tradit Chin Med , 2024 , 42 ( 11 ): 237 - 248 .
李荣胜 , 郑德 , 刘瑾 . 基于UHPLC-Q-Exactive Orbitrap HRMS技术分析痔血安合剂的化学成分与小鼠口服后的入血成分 [J]. 中国医院药学杂志 , 2023 , 43 ( 21 ): 2361 - 2372 .
LI R S , ZHENG D , LIU J . Analysis of chemical constituents in Zhixue'an mixture and its blood-entering components after oral administration in mice based on UHPLC-Q-exactive orbitrap HRMS [J]. Chin J Hosp Pharm , 2023 , 43 ( 21 ): 2361 - 2372 .
陈森杰 , 高思琦 , 王星星 , 等 . 基于UHPLC-Q-Orbitrap HRMS鉴定泽泻汤化学成分及小鼠体内成分组织分布特征 [J]. 中草药 , 2024 , 55 ( 24 ): 8336 - 8352 .
CHEN S J , GAO S Q , WANG X X , et al . Identification of chemical constituents in Zexie Decoction and tissue distribution characteristics of its components in mice based on UHPLC-Q-Orbitrap HRMS [J]. Chin Tradit Herb Drugs , 2024 , 55 ( 24 ): 8336 - 8352 .
ZHANG X , LI X Y , LIN N , et al . Diuretic activity of compatible triterpene components of Alismatis Rhizoma [J]. Molecules , 2017 , 22 ( 9 ): 1459 .
刘炳城 , 王昊 , 顾名博 , 等 . 泽泻及其药对的研究进展 [J]. 中华中医药学刊 , 2026 : 1 - 15 . https://link.cnki.net/urlid/21.1546.r.20260319.1048.010 https://link.cnki.net/urlid/21.1546.r.20260319.1048.010 .
LIU B C , WANG H , GU M B , et al . Research progress on Alismatis Rhizoma and its herb pairs [J]. Chin Arch Tradit Chin Med , 2026 : 1 - 15 . https://link.cnki.net/urlid/21.1546.r.20260319.1048.010 https://link.cnki.net/urlid/21.1546.r.20260319.1048.010 .
谢燕 , 李贵平 , 段月阳 , 等 . 泽泻提取物改善游离脂肪酸诱导的HepG2脂肪变性细胞模型的脂质代谢及氧化应激异常 [J]. 中草药 , 2024 , 55 ( 6 ): 2002 - 2012 .
XIE Y , LI G P , DUAN Y Y , et al . Alismatis Rhizoma extract ameliorates lipid metabolism and oxidative stress abnormalities in a free fatty acid-induced HepG2 steatosis cell model [J]. Chin Tradit Herb Drugs , 2024 , 55 ( 6 ): 2002 - 2012 .
AO X , YAN J , LIU S , et al . Extraction,isolation and identification of four phenolic compounds from Pleioblastus amarus shoots and their antioxidant and anti-inflammatory properties in vitro [J]. Food Chem , 2022 , 374 : 131743 .
MA Q , HAN L , BI X , et al . Structures and biological activities of the triterpenoids and sesquiterpenoids from Alisma orientale [J]. Phytochemistry , 2016 , 131 : 150 - 157 .
苏代丰 , 张鸿燕 , 周洁 , 等 . 基于UPLC-Q TOF-MS/MS探究泽泻醇G对3T3-L1前脂肪细胞分化过程中脂质代谢的影响 [J]. 药物分析杂志 , 2025 , 45 ( 8 ): 1347 - 1359 .
SU D F , ZHANG H Y , ZHOU J , et al . Effects of alisol G on lipid metabolism during the differentiation of 3T3-L1 preadipocytes based on UPLC-Q TOF-MS/MS [J]. Chin J Pharm Anal , 2025 , 45 ( 8 ): 1347 - 1359 .
SUN Y , YASUKAWA K . New anti-inflammatory ergostanetype ecdysteroids from the sclerotium of Polyporus umbellatus [J]. Bioorg Med Chem Lett , 2008 , 18 ( 11 ): 3417 - 3420 .
HOU X M , ZHANG Z Y , MA Y H , et al . Mechanism of hydroxysafflor yellow A on acute liver injury based on transcriptomics [J]. Front Pharmacol , 2022 , 13 : 966759 .
姚硕 , 李源 , 段超 , 等 . 白术内酯Ⅲ调节Hippo/YAP信号通路对非酒精性脂肪肝大鼠肝纤维化的影响 [J]. 河北医药 , 2024 , 46 ( 21 ): 3212 - 3216,3221 .
YAO S , LI Y , DUAN C , et al . Effect of atractylenolide Ⅲ regulating Hippo/YAP signaling pathway on liver fibrosis in rats with non-alcoholic fatty liver disease [J]. Hebei Med J , 2024 , 46 ( 21 ): 3212 - 3216,3221 .
ZHOU S , HUA S , CHEN X , et al . Zexieyin formula alleviates atherosclerosis by regulating SBAs levels through the FXR/FGF15 pathway and restoring intestinal barrier integrity [J]. Chin Med , 2025 , 20 ( 1 ): 68 .
0
浏览量
4
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621
